頭蓋内ステントの世界市場：市場規模（適応症別・製品種類別・エンドユーザー別・地域別）、将来予測

頭蓋内ステントの市場規模と予測

頭蓋内ステントの市場規模は、2024年に4億3,717万米ドルと評価され、2026年から2032年にかけてCAGR 8.65%で成長し、2032年には8億4,896万米ドルに達すると予測されています。

頭蓋内ステントは、様々な脳血管障害、特に不規則な血流や狭窄した動脈を特徴とする脳血管障害を治療するために、脳の血管内に埋め込む小型のチューブ状の医療機器です。これらのステントは、ニチノールやコバルトクロム合金のような生体適合性のある材料で作られていることが多く、自己拡張型かバルーンによる拡張型のいずれかになっています。ステントは、効き目が弱かったり制限されていたりする動脈を構造的に支え、動脈を開いた状態に保ち、脳の領域に十分な血流を送るために使用されます。この技術は脳卒中の予防、動脈瘤の修復、脳動脈硬化症などの疾患の管理に重要です。

頭蓋内ステントはさまざまな疾患の治療に使用されます。脳動脈瘤の治療では、血管壁を維持し破裂を防ぐためにステントが使用されます。また、虚血性脳卒中の治療、特に血栓を除去するために機械的血栓除去術が必要な場合にも使用されます。さらに、頭蓋内ステントは脳動脈狭窄の治療において、制限された動脈を広げ、正常な血流を回復させるという重要な役割を果たしています。これらのステントは、血管の完全性を回復するために正確な配置と有効性を確保するために、血管造影などの最新の画像診断技術とともに使用されます。

材料科学、画像技術、低侵襲手術の進歩。技術革新は、再狭窄や血栓症のリスクを低下させるために、生体適合性の改善と薬剤溶出機能を備えたステントの開発に集中すると思われます。さらに、血流や血管の状態をリアルタイムで監視するセンサーなどのスマート技術をステントに組み込むことで、継続的なデータを提供し、脳血管疾患の予防的管理を可能にすることで、患者ケアを一変させる可能性があります。研究が進むにつれて、脳ステントの使用は拡大し、より広範な神経血管障害の患者により良い治療結果をもたらし、新たな治療領域への使用拡大も期待できると予測されます。

世界の頭蓋内ステントの市場力学

世界の頭蓋内ステント市場を形成している主な市場力学は以下のとおりです：

主な市場促進要因：

脳血管疾患の発生率の上昇：脳卒中やアテローム性動脈硬化症などの脳血管疾患の発生率の増加が、頭蓋内ステント市場を牽引しています。世界の人口が高齢化するにつれて、これらの疾患の有病率が増加し、それらを適切に管理・治療するために頭蓋内ステント留置術のような最新の医療技術が必要とされています。この傾向は高齢化が進む豊かな国々で特に顕著で、効果的な脳血管治療に対する需要が急速に高まっています。

医療画像技術の進歩：高解像度MRIやCT血管造影などの医用画像技術は，脳血管疾患の同定と治療を一変させました。画像の向上により、頭蓋内ステントをより正確に留置できるようになり、その有効性と安全性が向上しました。この技術的進歩により、臨床医は複雑な脳動脈をよりよく観察し、ナビゲートできるようになったため、頭蓋内ステント留置治療が容易になり、手技のリスクが低下し、患者の転帰が向上しました。

ステント設計における技術革新：薬剤溶出性ステントや生体吸収性ステントの出現など、ステント設計における新たな開発が頭蓋内ステント市場を前進させています。これらの開発はステントの有効性を向上させ、再狭窄のリスクを低下させ、患者の長期予後を改善しようとするものです。生体適合性と柔軟性が改善された新素材と設計の登場は頭蓋内ステントの使用を後押しし、治療をより成功に導き、患者層を拡大しています。

支援的な政府のイニシアチブと政策：医療の成果を向上させることを目的としたこうした政策が、頭蓋内ステント市場の成長を促進しています。研究開発に資金を提供し、革新的な医療機器に補助金を与え、公的医療制度を改善するプログラムはすべて、頭蓋内ステントの使用増加に寄与しています。こうした政策は市場拡大を促進するだけでなく、より多くの国民が最先端の脳血管治療を受けられるようにするものでもあります。

主な課題

患者選択の複雑さ：頭蓋内ステント留置術の適切な適応患者を選ぶには、病変の形態、血管の解剖学的構造、併存疾患など、いくつかの側面を考慮する必要があります。患者選択基準の難しさは頭蓋内ステントの広範な使用を制限する可能性があり、治療成績を最適化するために広範な検討が必要となります。

スキルとトレーニングの必要条件：高度な画像診断技術やカテーテルを用いた治療を含む頭蓋内ステント留置術を実施するためには、神経インターベンション専門医はさまざまな専門知識とトレーニングを受けていなければなりません。熟練した人材の不足は、普及と品質保証の妨げとなる可能性があります。

新たな代替療法と技術：フローダイバータや外科手術などの代替療法の進歩は、頭蓋内ステント留置術にとって競合の脅威となります。刻々と変化する脳血管内治療において商業的価値を維持するためには、ステント技術は常に革新され、適応可能でなければなりません。

合併症と有害事象のリスク頭蓋内ステント留置術に伴うリスクには、血栓症、出血、血管穿孔などがあり、重篤な神経学的結果を引き起こす可能性があります。これらのリスクを管理するためには、高度に熟練した医師や専門的な施設を使用する必要があり、多様な患者集団に対して一貫した安全性と有効性を確保することは困難です。

主要動向：

薬剤溶出技術の統合：薬剤溶出性頭蓋内ステントの開発は、治療薬を治療部位に直接放出することで再狭窄を減少させることを意図しており、ベアメタルステントよりも長期的な有効性が向上する可能性があります。

新興市場と利用しやすい医療：新興国における医療インフラの成長と可処分所得の増加は、頭蓋内ステントの採用を促進し、最新の脳血管治療へのアクセスを向上させています。

規制の進展と標準化：規制チャンネルの合理化と頭蓋内ステントの使用に関する一貫した推奨事項の策定への取り組みは、製造と臨床の両面でデバイスの安全性、有効性、品質を保証することで市場の開拓を促進します。

個別化医療へのアプローチ：遺伝子プロファイリングとバイオマーカー探索の進歩により、頭蓋内ステントによる個々の患者の特性や疾患プロファイルに適合した個別化治療の選択肢が開かれつつあります。

目次

第1章 世界の頭蓋内ステント市場：イントロダクション

• 市場概要
• 分析範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの分析手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 世界の頭蓋内ステント市場の展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 世界の頭蓋内ステント市場：適応症別

• 概要
• 脳動脈瘤
• 頭蓋内狭窄

第6章 世界の頭蓋内ステント市場：製品種類別

• 概要
• ステント支援式コイル塞栓術
• バルーン拡張型ステント
• 自己拡張型ステント

第7章 世界の頭蓋内ステント市場：エンドユーザー別

• 概要
• 病院
• 外来手術センター
• その他

第8章 世界の頭蓋内ステント市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋
• 世界のその他の地域
  • ラテンアメリカ
  • 中東

第9章 世界の頭蓋内ステント市場の競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第10章 企業プロファイル

• Boston Scientific Corporation
• DePuy Synthes
• Medtronic
• Terumo Corporation
• Phenox
• Acandis
• Stryker Corporation
• Cook Medical
• MicroPort Scientific

第11章 付録

• 関連分析

Intracranial Stents Market Size And Forecast

Intracranial Stents Market size was valued at USD 437.17 Million in 2024 and is projected to reach USD 848.96 Million by 2032, growing at a CAGR of 8.65% from 2026 to 2032.

Intracranial stents are small, tube-like medical devices that are implanted within the brain's blood vessels to treat a variety of cerebrovascular disorders, particularly those characterized by irregular blood flow or narrowed arteries. These stents are often made of biocompatible materials like nitinol or cobalt-chromium alloy and can either self-expand or expand with a balloon. They are utilized to offer structural support to less effective or restricted arteries, keeping them open and allowing enough blood flow to brain areas. This technique is critical for preventing strokes, repairing aneurysms, and managing diseases like cerebral atherosclerosis.

Intracranial stents are used to treat a variety of medical disorders. The treatment of cerebral aneurysms is when stents are used to maintain the vascular wall and prevent rupture. They are also used to manage ischemic stroke, particularly when mechanical thrombectomy is required to remove a blood clot. Furthermore, intracranial stents play an important role in the treatment of cerebral artery stenosis by widening limited arteries and restoring normal blood flow. These stents are used with modern imaging techniques, such as angiography, to ensure exact placement and effectiveness in restoring vascular integrity.

Advancements in material science, imaging technologies, and minimally invasive surgery. Innovations are likely to focus on developing stents with improved biocompatibility and drug-eluting capabilities to lower the risk of restenosis and thrombosis. Furthermore, incorporating smart technology into stents, such as sensors for real-time monitoring of blood flow and vessel status, has the potential to transform patient care by giving continuous data and allowing for proactive management of cerebrovascular illnesses. As research advances, the use of cerebral stents is projected to grow, providing better outcomes for patients with a broader spectrum of neurovascular disorders and potentially expanding their usage to new therapeutic areas.

Global Intracranial Stents Market Dynamics

The key market dynamics that are shaping the global intracranial stents market include:

Key Market Drivers:

Rising Incidence of Cerebrovascular Diseases: The increasing incidence of cerebrovascular diseases, including stroke and atherosclerosis, is driving the intracranial stents market. As the world's population ages, the prevalence of these disorders increases, need modern medical techniques such as intracranial stenting to properly manage and treat them. This tendency is especially evident in affluent countries with aging populations, where the demand for effective cerebrovascular treatments is quickly increasing.

Advancements in Medical Imaging Technology: Medical imaging technology, such as high-resolution MRI and CT angiography, has transformed the identification and treatment of cerebrovascular diseases. Enhanced imaging enables more precise implantation of intracranial stents, improving their efficacy and safety. This technological advancement has facilitated the use of intracranial stenting treatments because clinicians can now better observe and navigate intricate cerebral arteries, lowering procedural risks and increasing patient outcomes.

Technological Innovations in Stent Design: New developments in stent design, such as the emergence of drug-eluting and bioresorbable stents, are moving the intracranial stents market ahead. These developments seek to improve stent efficacy, lower the risk of restenosis, and improve long-term patient outcomes. The arrival of new materials and designs with improved biocompatibility and flexibility has boosted the use of intracranial stents, making treatments more successful and expanding the patient pool.

Supportive Government Initiatives and Policies: These policies aimed at improving healthcare outcomes are driving growth in the intracranial stents market. Programs that fund research and development, give subsidies for innovative medical devices, and improve public healthcare systems all contribute to the rising use of intracranial stents. These policies not only promote market expansion but also ensure that a larger portion of the public has access to cutting-edge cerebrovascular treatments.

Key Challenges:

Complexity of Patient Selection: To select appropriate candidates for intracranial stenting, several aspects must be considered, including lesion morphology, vascular anatomy, and comorbidities. The difficulty of patient selection criteria can limit the broad use of intracranial stents, necessitating extensive review to optimize treatment outcomes.

Skill and Training Requirements: Neurointerventionalists must have different expertise and training to perform intracranial stenting, which includes advanced imaging techniques and catheter-based treatments. The scarcity of skilled personnel can impede widespread adoption and quality assurance.

Emerging Alternatives and Technologies: Advancements in alternative therapies, such as flow diverters and surgical procedures, pose competitive threats to intracranial stenting. To remain commercially relevant in the ever-changing landscape of cerebrovascular therapies, stent technology must be constantly innovated and adaptable.

Risk of Complications and Adverse Events: Risks associated with intracranial stenting procedures include thrombosis, bleeding, and blood vessel perforation which can cause severe neurological consequences. Managing these risks necessitates the use of highly skilled practitioners and specialized facilities, making it difficult to ensure consistent safety and efficacy across diverse patient populations.

Key Trends:

Integration of Drug-Eluting Technologies: The development of drug-eluting intracranial stents intends to reduce restenosis by releasing therapeutic drugs directly at the treatment site, with the potential for improved long-term efficacy over bare-metal stents.

Emerging Markets and Accessible Healthcare: Growing healthcare infrastructure and rising disposable budgets in emerging nations are encouraging increased adoption of intracranial stents, hence improving access to modern cerebrovascular treatments.

Regulatory Advancements and Standardization: Efforts to streamline regulatory channels and develop consistent recommendations for intracranial stent use drive market growth by guaranteeing device safety, efficacy, and quality in both production and clinical practice.

Personalized Medicine Approaches: Advances in genetic profiling and biomarker discovery are opening the way for individualized treatment options with intracranial stents that are matched to individual patient characteristics and illness profiles.

Global Intracranial Stents Market Regional Analysis

Here is a more detailed regional analysis of the global intracranial stents market:

North America:

North America dominates the global intracranial stents market, thanks to its strong healthcare infrastructure and broad use of new medical technology. The region benefits from a mature ecosystem of healthcare providers and research institutes that specialize in neurovascular treatments.

Major intracranial stent manufacturers are located or have large operations in North America, which promotes innovation and ensures access to cutting-edge therapies. The high frequency of cerebrovascular illnesses and neurological disorders, combined with robust regulatory frameworks that support medical device approvals, reinforces North America's dominance in the intracranial stents industry.

According to the Medicare Coverage Database, the intracranial arteries contribute to 8-10% of all ischemic strokes in the United States (Thijs et al., 2000). Intracranial artery stenosis is responsible for around 70,000 to 90,000 strokes or transient ischemic episodes (TIAs) per year (Chimowitz et al., 2005). The major intracranial arteries are the anterior and middle cerebral arteries, the basilar artery, and the vertebral artery's intracranial parts.

Asia Pacific:

The Asia Pacific region's intracranial stents market is expected to grow rapidly due to a combination of demographic and economic factors. A growing population with higher healthcare requirements, combined with rising occurrences of cerebrovascular illnesses and neurological problems, drives demand for improved neuro interventional treatments such as intracranial stenting. Furthermore, there is a growing awareness of preventive healthcare practices, which promote early detection and intervention, increasing the region's use of intracranial stents.

The growing middle class in Asia Pacific countries contributes significantly to market growth. With more disposable income, this demographic group desires access to modern medical technologies and procedures, such as intracranial stenting.

Increasing expenditures in healthcare infrastructure and the construction of specialist neurology clinics are improving access to neuro interventional operations, meeting Asia Pacific's growing demand for effective cerebrovascular therapies. These factors highlight the region's emergence as a key growth hub in the intracranial stents market.

Global Intracranial Stents Market: Segmentation Analysis

The Global Intracranial Stents Market is Segmented on the basis of Disease Indication, Product Type, End-User, And Geography.

Intracranial Stents Market, By Disease Indication

• Brain Aneurysm
• Intracranial Stenosis

Based on Disease Indication, the market is fragmented into Brain Aneurysm and Intracranial Stenosis. In the Intracranial Stents market, Intracranial Stenosis is expected to be the fastest-expanding category. This is being driven by the increasing prevalence of cerebrovascular disorders, which are a key risk factor for stenosis. Increased awareness and developments in diagnostic tools are allowing for earlier detection of stenosis, necessitating the insertion of stents to prevent stroke. Brain aneurysms are anticipated to have the largest share due to proven treatment approaches including stents, although stenosis is growing at a quicker rate due to an expanding pool of patients requiring this treatment.

Intracranial Stents Market, By Product Type

• Stent-Assisted Coil Embolization
• Balloon Expanding Stents
• Self-Expanding Stents

Based on Product Type, the market is segmented into Stent-Assisted Coil Embolization, Balloon Expanding Stents, and Self-Expanding Stents.

• Self-expanding stents are likely to take over due to their ease of use and adaptability to a variety of vessel geometries. However, balloon-expanding stents are predicted to be the most rapidly developing category. This is because they provide accurate positioning and improved control during deployment, which is increasingly important for complex processes.

Intracranial Stents Market, By End-User

• Hospitals
• Ambulatory Surgical Centers

Based on End-Users, the market is segmented into Hospitals and Ambulatory Surgical Centers. Hospitals are now the dominant segment in the intracranial stents market, owing to their well-equipped facilities and specialist surgeons for difficult intracranial stent surgeries. However, ambulatory surgery facilities are likely to be the most rapidly developing segment. Advances in minimally invasive stent installation techniques, combined with rising costs, have made these facilities a more cost-effective choice for certain procedures.

Intracranial Stents Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World
• On the basis of Geography, the Global Intracranial Stents Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to be the dominating area in the intracranial stents market. This is due to a mix of variables, including high healthcare costs, established infrastructure, and a big patient population with cerebrovascular illnesses. Asia Pacific is likely to experience the most rapid expansion. Rising disposable incomes, more understanding of stroke prevention, and an aging population making these conditions more likely all contribute to this trend.

Key Players

The "Global Intracranial Stents Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Boston Scientific Corporation, DePuy Synthes, Penumbra, Inc., Medtronic, Terumo Corporation, Phenox, Acandis, Stryker Corporation, Cook Medical, and MicroPort Scientific. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Intracranial Stents Market Recent Developments
• In September 2022, Phenox GmbH launched the pEGASUS HPC stent globally at the ESMINT 2022 congress in Nice, France. The pEGASUS HPC stent is the first stent of its kind to introduce coating technology for the treatment of ICAD and aneurysms.
• In June 2022, India Medtronic Private Limited, a wholly-owned subsidiary of Medtronic plc, announced a CE- certified fourth-generation flow diverter, PipelineTM Vantage with Shield Technology for endovascular treatment of brain aneurysms

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL INTRACRANIAL STENTS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL INTRACRANIAL STENTS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL INTRACRANIAL STENTS MARKET, BY DISEASE INDICATION

• 5.1 Overview
• 5.2 Brain Aneurysm
• 5.3 Intracranial Stenosis

6 GLOBAL INTRACRANIAL STENTS MARKET, BY PRODUCT TYPE

• 6.1 Overview
• 6.2 Stent-Assisted Coil Embolization
• 6.3 Balloon Expanding Stents
• 6.4 Self-Expanding Stents

7 GLOBAL INTRACRANIAL STENTS MARKET, BY END USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Ambulatory Surgical Centers
• 7.4 Others

8 GLOBAL INTRACRANIAL STENTS MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East

9 GLOBAL INTRACRANIAL STENTS MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Boston Scientific Corporation
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 DePuy Synthes
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Medtronic
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Terumo Corporation
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Phenox
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Acandis
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Stryker Corporation
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Cook Medical
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 MicroPort Scientific
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments

11 Appendix

• 11.1 Related Research